Suven Pharmaceuticals Limited (SUVENPHAR) — Capital Reinvestment Ratio
Latest as of September 2020:
0.24x
Suven Pharmaceuticals Limited (SUVENPHAR) has a Capital Reinvestment Ratio of 0.24x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.04 Billion) in capital expenditures (Rs248.54 Million). See SUVENPHAR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.24x
Capex / Operating Cash Flow
Operating Cash Flow
Rs1.04 Billion
INR
Capital Expenditures
Rs248.54 Million
INR
Data as of
Sep 2020
Most recent filing
Suven Pharmaceuticals Limited Capital Reinvestment Ratio (2019–2025)
This chart tracks Suven Pharmaceuticals Limited's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Capital Reinvestment Ratio for Suven Pharmaceuticals Limited from 2019 to 2025. For live market cap and broader valuation context, see market cap of Suven Pharmaceuticals Limited.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | Rs2.88 Billion | Rs1.56 Billion | ▲ +274.1% |
| 2024 | 0.14x | Rs3.58 Billion | Rs517.87 Million | ▼ -77.2% |
| 2023 | 0.63x | Rs4.51 Billion | Rs2.86 Billion | ▲ +178.2% |
| 2022 | 0.23x | Rs3.30 Billion | Rs751.87 Million | ▼ -21.2% |
| 2021 | 0.29x | Rs3.83 Billion | Rs1.11 Billion | ▲ +21.0% |
| 2020 | 0.24x | Rs4.16 Billion | Rs994.15 Million | ▼ -78.8% |
| 2019 | 1.13x | Rs504.05 Million | Rs567.86 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow